SCHEMBL1390243

SCHEMBL1390243

Cc1ccc(C(CC(=NO)c2ccc(=O)n(C)c2)c2ccc(-c3ccc(C(=O)O)cc3)cc2)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 4/20 0.47
CREBBP Q92793 1/20 0.34
MAP2K2 P36507 1/20 0.33
MAP2K1 Q02750 1/20 0.33
RXRA P19793 2/20 0.33
RXRB P28702 2/20 0.33
FFAR1 O14842 2/20 0.31
BRD4 O60885 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
HSD17B10 Q99714 1/20 0.31
DPP4 P27487 1/20 0.31
DPP7 Q9UHL4 1/20 0.31
KDM4C Q9H3R0 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA9 Q16790 1/20 0.30
KLKB1 P03952 1/20 0.30
MEN1 O00255 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390240 1.00 GPBAR1 (0.47) GPBAR1CREBBPMAP2K2MAP2K1RXRA
SCHEMBL1390242 1.00 GPBAR1 (0.47) GPBAR1CREBBPMAP2K2MAP2K1RXRA
SCHEMBL1389996 0.92 GPBAR1 (0.45) GPBAR1CREBBPRXRARXRBFFAR1
SCHEMBL1390000 0.92 GPBAR1 (0.45) GPBAR1CREBBPRXRARXRBFFAR1
SCHEMBL15949194 0.90 GPBAR1 (0.38) GPBAR1MAP2K2MAP2K1
SCHEMBL370021 0.90 GPBAR1 (0.44) GPBAR1CREBBPRXRARXRBFFAR1
SCHEMBL1389560 0.90 GPBAR1 (0.44) GPBAR1CREBBPRXRARXRBFFAR1
SCHEMBL368461 0.89 GPBAR1 (0.46) GPBAR1MAP2K2MAP2K1BRD4HTT
SCHEMBL368460 0.89 GPBAR1 (0.46) GPBAR1MAP2K2MAP2K1BRD4HTT
SCHEMBL368459 0.89 GPBAR1 (0.46) GPBAR1MAP2K2MAP2K1BRD4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885CREBBP 2198/4885MAP2K2 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.